How effective is FITNET-NHS for children and young adults with CFS/ME?
| ISRCTN | ISRCTN18020851 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN18020851 |
| Secondary identifying numbers | HTA 14/192/109 |
- Submission date
- 03/08/2016
- Registration date
- 04/08/2016
- Last edited
- 04/11/2024
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Nervous System Diseases
Plain English Summary
Current plain English summary as of 01/07/2019:
Background and study aims
Children who have Chronic Fatigue Syndrome or myalgic encephalomyelitis (CFS/ME) have fatigue that stops them going to school or doing other activities for more than 3 months. In England, up to 2 in 100 children have CFS/ME and 1% of secondary school children miss a day a week or more because of it. Most children with CFS/ME will recover if they receive specialist treatment, such as Cognitive Behaviour Therapy (CBT) or Activity Management. However, about 90% of children in the UK cannot have treatment because they live too far away from specialist services. For these children, probably only 8% will recover at 6 months. One solution is for these children to receive specialist CBT for CFS/ME using the internet at home. FITNET-NHS provides internet-based CBT for CFS/ME and has been shown to be effective in the Netherlands with 63% of children recovering at 6 months. We cannot use this treatment in the NHS until we know if children find it acceptable, and we know if it is effective and good value for money. We also need to know if FITNET-NHS will work in children with both CFS/ME and mood problems (one third of children with CFS/ME). The aim of this study is to test whether FITNET-NHS, a treatment delivered via the internet, is effective and value for money for children with CFS/ME.
Who can participate?
Children aged 11 to 17 years with CFS/ME who have no local specialist CFS/ME service
What does the study involve?
Participants are randomly allocated to be treated with either Activity Management or FITNET-NHS. Those who get Activity Management receive information on managing activities and sleep.They have six Skype calls (one assessment and five follow-up) with CFS specialist therapists to understand and provide advice on sleep and activity. The specialist therapist hands over care to the local GP or paediatrician but provides support to them with up to three phone calls. Those who get FITNET-NHS (and their parents) are given information and then work through up to 19 interactive CBT modules. Children are asked to do homework (answer questions and complete diaries). CBT-trained therapists make weekly appointments with the children and their parents to review homework and support behaviour change. Disability is assessed at 6 months, and fatigue, pain, quality of life, anxiety and depression are measured at 3, 6, 9 and 12 months, along with information on how much the NHS and families spend on treatment and whether parents return to work.
What are the possible benefits and risks of participating?
Most children in the UK are unable to access treatment because there is no local specialist service. Children who take part in this study will be offered treatment delivered by specialist CFS/ME therapists in both groups. If FITNET-NHS is effective, it may reduce NHS and wider costs to society, improve school attendance and quality of life, and change attitudes about paediatric CFS/ME being “untreatable” to being “treatable”. There is a small risk that the study may recruit children that do not have CFS/ME but instead have other disorders that present with fatigue. To avoid this we have put in place rigorous tests to ensure that other causes of fatigue are diagnosed and referred for appropriate treatment. If children are recruited with fatigue and other disorders, the treatment approaches offered are sufficiently generic approaches to fatigue, they are likely to benefit to some extent.
Where is the study run from?
Royal United Hospitals Bath NHS Foundation Trust (UK)
When is the study starting and how long is it expected to run for?
May 2016 to January 2022
Who is funding the study?
Health Technology Assessment Programme (UK)
Who is the main contact?
Prof. Esther Crawley
Previous plain English summary as of 09/07/2018:
Background and study aims
Children who have Chronic Fatigue Syndrome or myalgic encephalomyelitis (CFS/ME) have fatigue that stops them going to school or doing other activities for more than 3 months. In England, up to 2 in 100 children have CFS/ME and 1% of secondary school children miss a day a week or more because of it. Most children with CFS/ME will recover if they receive specialist treatment, such as Cognitive Behaviour Therapy (CBT) or Activity Management. However, about 90% of children in the UK cannot have treatment because they live too far away from specialist services. For these children, probably only 8% will recover at 6 months. One solution is for these children to receive specialist CBT for CFS/ME using the internet at home. FITNET-NHS provides internet-based CBT for CFS/ME and has been shown to be effective in the Netherlands with 63% of children recovering at 6 months. We cannot use this treatment in the NHS until we know if children find it acceptable, and we know if it is effective and good value for money. We also need to know if FITNET-NHS will work in children with both CFS/ME and mood problems (one third of children with CFS/ME). The aim of this study is to test whether FITNET-NHS, a treatment delivered via the internet, is effective and value for money for children with CFS/ME.
Who can participate?
Children aged 11 to 17 years with CFS/ME who have no local specialist CFS/ME service
What does the study involve?
Participants are randomly allocated to be treated with either Activity Management or FITNET-NHS. Those who get Activity Management receive information on managing activities and sleep.They have six Skype calls (one assessment and five follow-up) with CFS specialist therapists to understand and provide advice on sleep and activity. The specialist therapist hands over care to the local GP or paediatrician but provides support to them with up to three phone calls. Those who get FITNET-NHS (and their parents) are given information and then work through 19 interactive CBT modules. Children are asked to do homework (answer questions and complete diaries). CBT-trained therapists make weekly appointments with the children and their parents to review homework and support behaviour change. Disability is assessed at 6 months, and fatigue, pain, quality of life, anxiety and depression are measured at 3, 6, 9 and 12 months, along with information on how much the NHS and families spend on treatment and whether parents return to work.
What are the possible benefits and risks of participating?
Most children in the UK are unable to access treatment because there is no local specialist service. Children who take part in this study will be offered treatment delivered by specialist CFS/ME therapists in both groups. If FITNET-NHS is effective, it may reduce NHS and wider costs to society, improve school attendance and quality of life, and change attitudes about paediatric CFS/ME being “untreatable” to being “treatable”. There is a small risk that the study may recruit children that do not have CFS/ME but instead have other disorders that present with fatigue. To avoid this we have put in place rigorous tests to ensure that other causes of fatigue are diagnosed and referred for appropriate treatment. If children are recruited with fatigue and other disorders, the treatment approaches offered are sufficiently generic approaches to fatigue, they are likely to benefit to some extent.
Where is the study run from?
Royal United Hospitals Bath NHS Foundation Trust (UK)
When is the study starting and how long is it expected to run for?
May 2016 to October 2021
Who is funding the study?
Health Technology Assessment Programme (UK)
Who is the main contact?
Prof. Esther Crawley
Previous plain English summary:
Background and study aims
Children who have Chronic Fatigue Syndrome or myalgic encephalomyelitis (CFS/ME) have fatigue that stops them going to school or doing other activities for more than 3 months. In England, up to 2 in 100 children have CFS/ME and 1% of secondary school children miss a day a week or more because of it. Most children with CFS/ME will recover if they receive specialist treatment, such as Cognitive Behaviour Therapy (CBT) or Activity Management. However, about 90% of children in the UK cannot have treatment because they live too far away from specialist services. For these children, probably only 8% will recover at 6 months. One solution is for these children to receive specialist CBT for CFS/ME using the internet at home. FITNET-NHS provides internet-based CBT for CFS/ME and has been shown to be effective in the Netherlands with 63% of children recovering at 6 months. We cannot use this treatment in the NHS until we know if children find it acceptable, and we know if it is effective and good value for money. We also need to know if FITNET-NHS will work in children with both CFS/ME and mood problems (one third of children with CFS/ME). The aim of this study is to test whether FITNET-NHS, a treatment delivered via the internet, is effective and value for money for children with CFS/ME.
Who can participate?
Children aged 11 to 17 years with CFS/ME who have no local specialist CFS/ME service
What does the study involve?
Participants are randomly allocated to be treated with either Activity Management or FITNET-NHS. Those who get Activity Management receive information on managing activities and sleep. They have three Skype calls (one assessment and two follow up) with CFS specialist therapists to understand and provide advice on sleep and activity. The specialist therapist hands over care to the local GP or paediatrician but provides support to them with up to three phone calls. Those who get FITNET-NHS (and their parents) are given information and then work through 19 interactive CBT modules. Children are asked to do homework (answer questions and complete diaries). CBT-trained therapists make weekly appointments with the children and their parents to review homework and support behaviour change. Disability is assessed at 6 months, and fatigue, pain, quality of life, anxiety and depression are measured at 3, 6, 9 and 12 months, along with information on how much the NHS and families spend on treatment and whether parents return to work.
What are the possible benefits and risks of participating?
Most children in the UK are unable to access treatment because there is no local specialist service. Children who take part in this study will be offered treatment delivered by specialist CFS/ME therapists in both groups. If FITNET-NHS is effective, it may reduce NHS and wider costs to society, improve school attendance and quality of life, and change attitudes about paediatric CFS/ME being “untreatable” to being “treatable”. There is a small risk that the study may recruit children that do not have CFS/ME but instead have other disorders that present with fatigue. To avoid this we have put in place rigorous tests to ensure that other causes of fatigue are diagnosed and referred for appropriate treatment. If children are recruited with fatigue and other disorders, the treatment approaches offered are sufficiently generic approaches to fatigue, they are likely to benefit to some extent.
Where is the study run from?
Royal United Hospitals Bath NHS Foundation Trust (UK)
When is the study starting and how long is it expected to run for?
May 2016 to October 2021
Who is funding the study?
Health Technology Assessment Programme (UK)
Who is the main contact?
Prof. Esther Crawley
Contact information
Scientific
Centre for Academic Child Health
Population Health Sciences
University of Bristol
Bristol
BS8 1NU
United Kingdom
 ORCID ID |
0000-0002-2521-0747 |
|---|---|
| Phone | +44 (0)1225 821340 |
| fitnet-nhs@bristol.ac.uk |
Study information
| Study design | Single-centre randomised controlled trial |
|---|---|
| Primary study design | Interventional |
| Secondary study design | Randomised controlled trial |
| Study setting(s) | Internet/virtual |
| Study type | Treatment |
| Participant information sheet | http://www.bristol.ac.uk/fitnet-nhs |
| Scientific title | Investigating the effectiveness and cost-effectiveness of using FITNET-NHS (Fatigue In Teenagers on the interNET in the NHS) compared to Activity Management to treat paediatric Chronic Fatigue Syndrome (CFS)/Myalgic Encephalomyelitis (ME) in the United Kingdom: a randomised controlled trial (FITNET-NHS) |
| Study acronym | FITNET-NHS |
| Study hypothesis | FITNET-NHS is more effective and cost-effective than Activity Management for treating paediatric CFS/ME. More details can be found at: http://www.nets.nihr.ac.uk/projects/hta/14192109 |
| Ethics approval(s) | Frenchay Research Ethics Committee, 10/10/2016, ref: 16/SW/0268 |
| Condition | Paediatric CFS/ME |
| Intervention | Current interventions as of 09/07/2018: A single-centre randomised controlled trial investigating the effectiveness and cost-effectiveness of using FITNET-NHS (internet delivered cognitive behavioural therapy) compared to Activity Management to treat paediatric Chronic Fatigue Syndrome (CFS)/Myalgic Encephalomyelitis (ME) in the United Kingdom. Participants will be allocated in a 1:1 ratio, minimised by age and gender, to each of the interventions. An internal pilot study has been conducted with continuation of the trial based on achieving defined stop criteria. Integrated qualitative research methods have been used to optimise recruitment and retention. Activity Management arm (comparator): specialist CFS/ME occupational therapists deliver activity management over a series of video calls to the participants. This includes help with activity management, symptom management, sleep and problem solving. FITNET-NHS arm (intervention): The FITNET-NHS intervention delivers specialist cognitive behavioural therapy (CBT) for CFS/ME via the internet at home. Participants and their parents work through up to 19 modules and have e-consultations with CBT therapists. Previous interventions: A single-centre randomised controlled trial investigating the effectiveness and cost-effectiveness of using FITNET-NHS (internet delivered cognitive behavioural therapy) compared to Activity Management to treat paediatric Chronic Fatigue Syndrome (CFS)/Myalgic Encephalomyelitis (ME) in the United Kingdom. Participants will be allocated in a 1:1 ratio, minimised by age and gender, to each of the interventions. An internal pilot study will be conducted with continuation of the trial based on achieving defined stop criteria. Integrated qualitative research methods will be used to optimise recruitment and retention. Activity Management arm (comparator): specialist CFS/ME occupational therapists delivery activity management over video call to the participants. This includes help with activity management, symptom management, sleep and problem solving. FITNET-NHS arm (intervention): The FITNET-NHS intervention delivers specialist cognitive behavioural therapy (CBT) for CFS/ME via the internet at home. Participants and their parents work through 21 modules (Amended on 01/09/2017 to 19 modules) and have e-consultations with CBT therapists. |
| Intervention type | Behavioural |
| Primary outcome measure | Disability measured using the Physical Function Scale (SF-36-PFS) at 6 months after randomisation |
| Secondary outcome measures | Secondary outcomes are measured at 3, 6 and 12 months unless otherwise specified, and include: 1. SF36-PFS measured at 3 and 12 months after randomisation 2. Fatigue (Chalder scale and Checklist Individual Strength (CIS) fatigue severity subscale) 3. School attendance (self-report school or home tuition) 4. Mood (Revised Children’s Anxiety and Depression Scale (RCADS)) 5. Pain visual analogue scale 6. Clinical Global Impression Scale 7. Quality of Life (EQ-5D-Y) 8. Parental completed: Healthcare Resource Use questionnaire 9. Parental completed: Work Productivity & Activity Impairment Questionnaire General Health (WPAI:GH) |
| Overall study start date | 01/05/2016 |
| Overall study end date | 12/01/2022 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Child |
| Lower age limit | 11 Years |
| Upper age limit | 17 Years |
| Sex | Both |
| Target number of participants | 314 |
| Total final enrolment | 314 |
| Participant inclusion criteria | 1. Children aged 11 to 17 years 2. Children with CFS/ME (defined using NICE guidance) 3. Children with no local specialist CFS/ME service |
| Participant exclusion criteria | 1. Children not disabled by fatigue 2. Children whose fatigue is due to another cause 3. Children or parents unable to complete video calls (e.g. Skype) or FITNET-NHS modules (e.g. unable to read FITNET-NHS material, or significant development problems, or limited internet access, unwilling/unable to set up personal email address/video call (e.g. Skype) account) |
| Recruitment start date | 01/11/2016 |
| Recruitment end date | 11/11/2020 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
United Kingdom
Sponsor information
University/education
Research and Enterprise Development
One Cathedral Square
Bristol
BS1 5DD
England
United Kingdom
"ROR" |
https://ror.org/0524sp257 |
|---|
Funders
Funder type
Government
Government organisation / National government
- Alternative name(s)
- NIHR Health Technology Assessment Programme, HTA
- Location
- United Kingdom
Results and Publications
| Intention to publish date | 30/04/2023 |
|---|---|
| Individual participant data (IPD) Intention to share | Yes |
| IPD sharing plan summary | Available on request |
| Publication and dissemination plan | We intend to publish the protocol, the results of the internal pilot and the results of the full trial. |
| IPD sharing plan | Given the nature of this data set, access is controlled. Requests are referred to the University of Bristol Data Access Committee (DAC) for approval before data can be released under an appropriate data access agreement. For details on how to access data please see the data repository search record at https://data.bris.ac.uk/data/. |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Protocol article | protocol | 22/02/2018 | 23/12/2019 | Yes | No |
| Protocol article | protocol update | 19/12/2019 | 23/12/2019 | Yes | No |
| Results article | pilot phase results | 12/08/2020 | 17/08/2020 | Yes | No |
| Statistical Analysis Plan | version 1 | 06/10/2021 | 08/11/2021 | No | No |
| HRA research summary | 28/06/2023 | No | No | ||
| Results article | 31/10/2024 | 04/11/2024 | Yes | No |
Additional files
Editorial Notes
04/11/2024: Publication reference added.
18/03/2022: The overall trial end date has been changed from 31/03/2022 to 12/01/2022.
18/01/2022: The overall trial end date has been changed from 30/04/2022 to 31/03/2022 and the plain English summary has been updated accordingly.
08/11/2021: Uploaded statistical analysis plan.
04/10/2021: The following changes have been made:
1. The recruitment end date has been changed from 30/11/2020 to 11/11/2020.
2. The final enrolment number has been added.
24/11/2020: IPD sharing statement added.
04/11/2020: The following changes were made to the trial record:
1. The overall end date was changed from 31/01/2022 to 30/04/2022.
2. The plain English summary was updated to reflect these changes.
22/10/2020: The recruitment end date was changed from 31/10/2020 to 30/11/2020.
16/10/2020: Internal review.
14/10/2020: The overall trial end date was changed from 30/04/2022 to 31/01/2022.
17/08/2020: Publication reference added.
12/06/2020: The scientific contact details have been changed.
23/12/2019: 2018 and 2019 publication references added.
01/07/2019: The following changes were made:
1. The plain English summary was updated.
2. The contact details were updated.
3. The link to the participant information sheet was added.
4. The overall trial end date was updated from 30/10/2021 to 30/04/2022.
5. The target number of participants was updated from 734 to 314.
6. The recruitment end date was updated from 30/04/2020 to 31/10/2020.
7. The intention to publish date was updated from 30/10/2022 to 30/04/2023.
8. The sponsor contact details were updated.
09/07/2018: The following changes have been made:
1. The interventions have been changed.
2. The plain English summary has been changed.
04/09/2017: Ethics approval information added. Interventions and Plain English summary have been updated.
